Showing 1 - 7 of 7
Artificial intelligence (AI) has the potential to make health care more effective, efficient and equitable. AI applications are on the rise, from clinical decision-making and public health, to biomedical research and drug development, to health system administration and service redesign. The...
Persistent link: https://www.econbiz.de/10012630505
At the onset of the COVID-19 pandemic many countries found that they lacked basic, timely data for decision making—such as information on health workforce, resources, hospitalisations, and mortality. Many policy makers have since leveraged COVID-19 related information system reforms in a way...
Persistent link: https://www.econbiz.de/10013202466
The strengthening of health data infrastructure and governance is a policy priority of the OECD. This report presents findings from the 2019-20 OECD survey of health data development, use and governance. Health ministries and health data authorities in twenty-three countries responded to the...
Persistent link: https://www.econbiz.de/10012630303
Innovative providers’ payment models represent an important policy lever that could be used to promote value-based health systems. By bundling services across the continuum of care or to target acute events or chronic conditions, innovative payment models set financial incentives for providers...
Persistent link: https://www.econbiz.de/10014278814
About one in ten patients are harmed during health care. This paper estimates the health, financial and economic costs of this harm. Results indicate that patient harm exerts a considerable global health burden. The financial cost on health systems is also considerable and if the flow-on...
Persistent link: https://www.econbiz.de/10011695017
Across OECD countries, two in three people aged over 65 years live with at least one chronic condition often requiring multiple interactions with different providers, making them more susceptible to poor and fragmented care. This has prompted calls for making health systems more people-centred,...
Persistent link: https://www.econbiz.de/10013278686
We examine provider responses to the expansion of public subsidies in 2015 for oral chemotherapy treatment, in a health system where providers were free to determine their own prices. Oral chemotherapy treatment was known to have similar efficacy to its traditional intravenous alternative and...
Persistent link: https://www.econbiz.de/10014249952